Screening for diabetes: what are we really doing?
作者信息
Goyder E, Irwig L
机构信息
Department of Public Health and Community Medicine, University of Sydney, New South Wales 2006, Australia.
出版信息
BMJ. 1998 Dec 12;317(7173):1644-6. doi: 10.1136/bmj.317.7173.1644.
Abstract
摘要
相似文献
1
Screening for diabetes: what are we really doing?糖尿病筛查：我们究竟在做什么？
BMJ. 1998 Dec 12;317(7173):1644-6. doi: 10.1136/bmj.317.7173.1644.
2
Screening for gestational diabetes mellitus.妊娠期糖尿病筛查
Am Fam Physician. 2004 Mar 1;69(5):1187-8.
3
Screening for active tuberculosis in a diabetes mellitus clinic in Soweto, South Africa.南非索韦托一家糖尿病诊所中活动性肺结核的筛查
Int J Tuberc Lung Dis. 2016 Jul;20(7):992-3. doi: 10.5588/ijtld.16.0340.
4
Summaries for patients. A new diabetes screening score.患者摘要。一种新的糖尿病筛查评分。
Ann Intern Med. 2009 Dec 1;151(11):I27-I28. doi: 10.7326/0003-4819-151-11-200912010-00001.
5
[Mass screening for diabetes mellitus by use of a rapid method of determination of glycosuria].[采用快速检测糖尿方法进行糖尿病群体筛查]
Rev Med Chir Soc Med Nat Iasi. 1974 Oct-Dec;78(4):961-2.
6
[Use of logical decision rules during screening in order to identify groups at risk for diabetes mellitus].[在筛查过程中使用逻辑决策规则以识别糖尿病风险人群]
Probl Endokrinol (Mosk). 1991 May-Jun;37(3):10-2.
7
The Finnish Diabetes Risk Score (FINDRISC) and other non-invasive scores for screening of hepatic steatosis and associated cardiometabolic risk.
Ann Med. 2011;43(6):413-7. doi: 10.3109/07853890.2011.579152. Epub 2011 May 23.
8
Screening for diabetes in Kuwait and evaluation of risk scores.科威特的糖尿病筛查及风险评分评估。
East Mediterr Health J. 2010 Jul;16(7):725-31.
9
Indian Diabetes Risk Score.印度糖尿病风险评分
J Assoc Physicians India. 2005 Sep;53:755-7.
10
The Cochrane Collaborative Diabetes Review Group.考科蓝协作网糖尿病综述小组
Diabet Med. 1996 Apr;13(4):390-1. doi: 10.1002/(SICI)1096-9136(199604)13:4<390::AID-DIA121>3.0.CO;2-4.
引用本文的文献
1
Prevalent, uncontrolled, and undiagnosed diabetes mellitus among urban adults in Dire Dawa, Eastern Ethiopia: A population-based cross-sectional study.埃塞俄比亚东部迪雷达瓦市成年人口中普遍存在、未得到控制且未被诊断出的糖尿病：一项基于人群的横断面研究。
SAGE Open Med. 2020 Nov 20;8:2050312120975235. doi: 10.1177/2050312120975235. eCollection 2020.
2
Diabetes-related symptoms and negative mood in participants of a targeted population-screening program for type 2 diabetes: The Hoorn Screening Study.2型糖尿病目标人群筛查项目参与者的糖尿病相关症状及负面情绪：霍伦筛查研究
Qual Life Res. 2005 Aug;14(6):1501-9. doi: 10.1007/s11136-004-0028-3.
3
Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus.改善2型糖尿病患者治疗建议依从性的干预措施。
Cochrane Database Syst Rev. 2005 Apr 18;2005(2):CD003638. doi: 10.1002/14651858.CD003638.pub2.
4
Impaired glucose tolerance: qualitative and quantitative study of general practitioners' knowledge and perceptions.糖耐量受损：全科医生知识与认知的定性和定量研究
BMJ. 2002 May 18;324(7347):1190. doi: 10.1136/bmj.324.7347.1190.
5
Preventive medicine in people at high risk for chronic disease: the value of identifying and treating diabetes.慢性病高危人群的预防医学：识别与治疗糖尿病的价值
CMAJ. 1999 Jun 1;160(11):1593-5; discussion 1595-6.
6
The folly of population screening for type 2 diabetes.2型糖尿病人群筛查的弊端。
CMAJ. 1999 Jun 1;160(11):1592-3.
本文引用的文献
1
High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study.高血糖浓度是中年非糖尿病男性死亡的一个风险因素。怀特霍尔研究、巴黎前瞻性研究和赫尔辛基警察研究中的20年随访。
Diabetes Care. 1998 Mar;21(3):360-7. doi: 10.2337/diacare.21.3.360.
2
The effects of improved glycemic control on complications in type 2 diabetes.血糖控制改善对2型糖尿病并发症的影响。
Arch Intern Med. 1998 Jan 26;158(2):134-40. doi: 10.1001/archinte.158.2.134.
3
The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.全国高血压防治联合委员会第六次报告。
Arch Intern Med. 1997 Nov 24;157(21):2413-46. doi: 10.1001/archinte.157.21.2413.
4
Adverse effects of screening for gestational diabetes: a prospective cohort study in Toronto, Canada.妊娠期糖尿病筛查的不良影响：加拿大多伦多的一项前瞻性队列研究。
J Med Screen. 1997;4(3):128-32. doi: 10.1177/096914139700400303.
5
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.糖尿病诊断与分类专家委员会报告
Diabetes Care. 1997 Jul;20(7):1183-97. doi: 10.2337/diacare.20.7.1183.
6
Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia.非胰岛素依赖型糖尿病并发症模型。II. 以血糖正常为目标治疗非胰岛素依赖型糖尿病的健康益处和成本效益分析。
Diabetes Care. 1997 May;20(5):735-44. doi: 10.2337/diacare.20.5.735.
7
Model of complications of NIDDM. I. Model construction and assumptions.非胰岛素依赖型糖尿病并发症模型。I. 模型构建与假设。
Diabetes Care. 1997 May;20(5):725-34. doi: 10.2337/diacare.20.5.725.
8
Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S).辛伐他汀降低胆固醇可改善糖尿病合并冠心病患者的预后。斯堪的纳维亚辛伐他汀生存研究（4S）的亚组分析。
Diabetes Care. 1997 Apr;20(4):614-20. doi: 10.2337/diacare.20.4.614.
9
Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.基于利尿剂的降压治疗对老年单纯收缩期高血压糖尿病患者心血管疾病风险的影响。老年收缩期高血压计划合作研究组。
JAMA. 1996 Dec 18;276(23):1886-92.
10
Treating hypertension.治疗高血压。
J Hypertens. 1996 Jul;14(7):813-4. doi: 10.1097/00004872-199607000-00002.
Zotero 插件